Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Bristol-Myers Squibb BMY Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,750	Closed	-$472K	–	192
2025 Q4	$472K	Sell	8,750 -11,250	-56%	-$541K	0.18%	104
2025 Q3	$902K	Hold	20,000	–	–	0.36%	72
2025 Q2	$926K	Buy	+20,000	New	+$982K	0.37%	76
2024 Q4	–	Sell	-182	Closed	-$9.42K	–	182
2024 Q3	$9.42K	Buy	+182	New	+$8.54K	﹤0.01%	173
2024 Q1	–	Sell	-100	Closed	-$5.13K	–	172
2023 Q4	$5.13K	Hold	100	–	–	﹤0.01%	180
2023 Q3	$5.8K	Buy	+100	New	+$6.13K	﹤0.01%	156

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's BMY Position: Q1 2026 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 8,750 shares — an estimated $472K sold.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in BMY in Q3 2023 and held it in 6 quarters. The position peaked at $926K in Q2 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna sold 8,750 Bristol-Myers Squibb shares in Q1 2026, an estimated $472K.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Bristol-Myers Squibb in Q3 2023 and held it in 6 quarters.
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's Bristol-Myers Squibb position peaked at $926K in Q2 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q1 2026, filed 14 May 2026.